Literature DB >> 25588323

In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Pajaree Chariyavilaskul1, Poonsin Poungpairoj, Suchada Chaisawadi, Chanchai Boonla, Thasinas Dissayabutra, Phisit Prapunwattana, Piyaratana Tosukhowong.   

Abstract

Hypocitraturia, hypokaliuria, and increased oxidative stress are common lithogenic risk factors found in nephrolithiasis patients, especially in Thailand. We previously developed lime powder regimen (LPR), and demonstrated that LPR delivered citraturic, alkalinizing, and antioxidative effects in kidney stone patients. In this study, in vitro anti-lithogenic activity, in vivo acute toxicity, and crossover-designed phase 1 trial (in 13 healthy volunteers) of LPR were investigated. LPR inhibited the growth of calcium oxalate monohydrate (COM) crystals in dose-dependent manner, and inhibited the intracellular production of reactive oxygen species (ROS) in COM-treated HK-2 cells. LPR did not significantly alter viability of HK-2 cells. No acute toxicity was detected in mice orally fed with LPR (10 g/kg). No adverse effect and complaint of LPR ingestion (5 g/dose) were observed in the tested volunteers. Plasma citrate was elevated at 30 min after LPR load, which was higher than the water load control. Plasma potassium was significantly elevated at 30 min after LPR load and remained high for 2 h, and at 2 h, it was significantly higher than the water load. Urinary citrate was significantly increased at 1 h after LPR load and remained high for 2 h, and at 2 h, it was significantly higher than the water load. Urinary potassium was significantly increased at 1 h after LPR load and remained high for 3 h, and its levels at 1, 2, and 3 h were significantly higher than the water load. Urinary total antioxidant status was significantly increased at 2 h after LPR load. In conclusion, LPR had an inhibitory effect on COM growth and exerted as antioxidant to attenuate ROS production in the COM-treated renal tubular cells. LPR provided citraturic, kaliuric, and antioxidative responses in healthy individuals without any adverse events. This suggests that LPR is well tolerated and safe for daily consumption.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25588323     DOI: 10.1007/s00240-015-0751-y

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  39 in total

Review 1.  Medical management of urinary stone disease.

Authors:  Charles Y C Pak
Journal:  Nephron Clin Pract       Date:  2004

Review 2.  Diet and fluid prescription in stone disease.

Authors:  E N Taylor; G C Curhan
Journal:  Kidney Int       Date:  2006-07-12       Impact factor: 10.612

Review 3.  Regulation of nausea and vomiting by cannabinoids.

Authors:  Linda A Parker; Erin M Rock; Cheryl L Limebeer
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 4.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

5.  Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi.

Authors:  Chanchai Boonla; Kerstin Krieglstein; Sombat Bovornpadungkitti; Frank Strutz; Björn Spittau; Chagkrapan Predanon; Piyaratana Tosukhowong
Journal:  BJU Int       Date:  2011-03-16       Impact factor: 5.588

Review 6.  Dietary therapy for patients with hypocitraturic nephrolithiasis.

Authors:  Michael P Kurtz; Brian H Eisner
Journal:  Nat Rev Urol       Date:  2011-02-15       Impact factor: 14.432

7.  Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products.

Authors:  Kristina L Penniston; Stephen Y Nakada; Ross P Holmes; Dean G Assimos
Journal:  J Endourol       Date:  2008-03       Impact factor: 2.942

8.  Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.

Authors:  Ming-Chieh Ma; Yih-Sharng Chen; Ho-Shiang Huang
Journal:  Urology       Date:  2013-12-19       Impact factor: 2.649

9.  Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.

Authors:  Piyaratana Tosukhowong; Sombat Borvonpadungkitti; Vitoon Prasongwatana; Kriang Tungsanga; Srisakul Jutuporn; Thasinas Dissayabutr; Sirirat Reungjui; Pote Sriboonlue
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

10.  Lemon juice has protective activity in a rat urolithiasis model.

Authors:  Mohammed Touhami; Amine Laroubi; Khadija Elhabazi; Farouk Loubna; Ibtissam Zrara; Younes Eljahiri; Abdelkhalek Oussama; Félix Grases; Abderrahman Chait
Journal:  BMC Urol       Date:  2007-10-05       Impact factor: 2.264

View more
  1 in total

1.  Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis.

Authors:  Piyaratana Tosukhowong; Pimsuda Kulpradit; Sakdithep Chaiyarit; Wattanachai Ungjareonwattana; Nuttiya Kalpongnukul; Supoj Ratchanon; Visith Thongboonkerd
Journal:  Urolithiasis       Date:  2017-06-05       Impact factor: 3.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.